BioXcel Therapeutics, Inc.
BTAI$1.23▲ 6.03% 24h
BioXcel Therapeutics, Inc.BTAI$1.23
-$0.0338(-2.67%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$33.30M
P/E ratio
—
EPS (diluted)
$-5.73
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$642,000
Net income
$-69.90M
Net margin
-10887.4%
Gross margin
—
Dividends & financials
BioXcel Therapeutics, Inc. (BTAI) reported revenue of $642,000 and net income of $-69.90M, or $-5.73 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.